CDC Panel Recommends Resuming Use of J&J COVID Vaccine
FRIDAY, April 23, 2021 — The United States should resume administering the Johnson & Johnson COVID-19 vaccine, a key advisory panel for the Centers for Disease Control and Prevention voted on Friday. The agency’s Advisory Committee on Immunization Practices (ACIP) has determined that the benefits of the vaccine in preventing deaths and hospitalizations far outweigh… Read More »